LIMN — Liminatus Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Liminatus Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	—	0.336	0.281	0.156	0.065
Net Total Receivables	—	0.001	0.001	0.054	0.006
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.299	0.422	0.361	0.211	0.813
Long Term Investments
Total Assets	0.299	276	15.5	4.5	2.83
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.275	1.38	3.59	5.16	8.68
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	0.275	21.6	14.2	15.2	18.7
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	0.024	255	1.29	-10.7	-15.9
Total Liabilities & Shareholders' Equity	0.299	276	15.5	4.5	2.83
Total Common Shares Outstanding